NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. ("SNDL" or the "Company") (NASDAQ:SNDL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SNDL and certain of its officers and/or directors […]
NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of LENZ Therapeutics, Inc. ("LENZ" or the "Company") (NASDAQ:LENZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether LENZ and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lakeland Industries, Inc. ("Lakeland" or the "Company") (NASDAQ:LAKE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lakeland and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company ("Graphic Packaging" or the "Company") (NYSE:GPK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Graphic Packaging and certain of
NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. ("Aerovironment" or the "Company") (NASDAQ:AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aerovironment and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ardent and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Galectin Therapeutics Inc. ("Galectin" or the "Company") (NASDAQ:GALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galectin and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Duluth Holdings Inc. ("Duluth" or the "Company") (NASDAQ:DLTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Duluth and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / December 24, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Insmed Incorporated ("Insmed" or the "Company") (NASDAQ:INSM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Insmed and certain of its officers and/or directors
NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ:TLX) securities. If you suffered a loss on your Telix Pharmaceuticals Ltd. investment and would like to explore